![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2358 | Ordered by Position (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Buhl, Thomas (Global Bioenergies 201606 Head of Business Development) | Business Development Manager / Strategy Manager | Global Bioenergies (Group) | Île-de-France (region) |
| Carouge, Dominique (Sanofi 201802– EVP Head of Business Transformation joined Sanofi 2009 before Ernst & Young) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Chaud, Bernard (Global Bioenergies 201702 Head of Industrial Strategy) | Business Development Manager / Strategy Manager | Global Bioenergies (Group) | Île-de-France (region) |
| Clewlow, Paul J. (Sygnature Discovery 202101– Board Member before SVP Business Development) | Business Development Manager / Strategy Manager | Sygnature Discovery (Group) | East Midlands (region) |
| Contrastin, Mikael (EG 427 202103 VP Strategy + Engineering) | Business Development Manager / Strategy Manager | EG 427 (FR, Pinpoint Gene Therapy) | Île-de-France (region) |
| Cronin, Kevin (Protein Metrics 202011– VP of Corporate Development before Core Informatics + Biovia + Symyx) | Business Development Manager / Strategy Manager | Insightful Science (Group) | California (federal state) |
| Da Costa, Daniel (Inoviem Scientific 201312– Business Development Manager) | Business Development Manager / Strategy Manager | Inoviem Scientific (FR) | Grand Est (Great East) (region) |
| Daniel, Thomas (Vivet Therapeutics 201806 Business Development Director) | Business Development Manager / Strategy Manager | Vívet Therapeutics (Group) | Île-de-France (region) |
| Dessertenne, Eric (Biocorp (FR) 201507 Head Commercial Operations + Business Development) | Business Development Manager / Strategy Manager | Biocorp (Alternext: ALCOR) | Auvergne-Rhône-Alpes (region) |
| Do, Hervé (Peptinov 201508 VP Business Development joined 2009) | Business Development Manager / Strategy Manager | Peptinov SAS | Île-de-France (region) |
| Douglas, James (Exonhit– VP 200801 Corp Developm before Epigenomics 200601–200712 before Biosite) | Business Development Manager / Strategy Manager | Eurobio Scientific (Group) | Île-de-France (region) |
| Dusek, Alex (Erytech 201805– VP Commercial Strategy before Argos Therapeutics + Bayer HealthCare + United Therapeutics) | Business Development Manager / Strategy Manager | Erytech (Group) | Massachusetts (federal state) |
| Erroba, Elena (Infarco 201611 Business Development Director at 3P Biopharmaceuticals) | Business Development Manager / Strategy Manager | 3P Biopharmaceuticals S.L. | Navarre (Navarra) |
| Fages, Carole (Nucleis 200504 Director BusDev) | Business Development Manager / Strategy Manager | Nucleis S.A. | Auvergne-Rhône-Alpes (region) |
| Godard, Augustin (INSERM 201509 Open Innovation Manager at Inserm Transfert) | Business Development Manager / Strategy Manager | France (govt) | Île-de-France (region) |
| Grossman, Paul D. (Life Technologies 200903 SVP Corporate Development & Strategy before Applied Biosystems) | Business Development Manager / Strategy Manager | Thermo Fisher (Group) | California (federal state) |
| Guyon-Gellin, Delphine (Osivax 202007 Chief Business Development Officer) | Business Development Manager / Strategy Manager | Osivax (Group) | Auvergne-Rhône-Alpes (region) |
| Guyon-Gellin, Nicolas (Enyo Pharma 201805– VP Corp Development + Strategy before Morgan Stanley + Exane BNP + Amundi) | Business Development Manager / Strategy Manager | Enyo Pharma S.A. | Auvergne-Rhône-Alpes (region) |
| Hays, Anne (Lonza 201412 Head Custom Development Services Organisation) | Business Development Manager / Strategy Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Hilbert, Helmut (Curetis 201303– Head Business Development before Qiagen Business Development) | Business Development Manager / Strategy Manager | OpGen (Group) | Baden-Württemberg (federal state) |
| Holder, Jean-Marc (SeqOne 202201 Chief Strategy + Innovation Officer + Co-Founder) | Business Development Manager / Strategy Manager | SeqOne SAS (SeqOne Genomics) | Occitanie (Occitania) (region) |
| Honisch, Christiane (Evotec 202302 SVP Head of Diagnostics before Eppendorf + Illumina + Roche + Sequenom) | Business Development Manager / Strategy Manager | Evotec (Group) | Hamburg (federal state) |
| Hultén, Corrie (SK Group 202202– Executive Director Business Development before Porton Advanced + Patheon) | Business Development Manager / Strategy Manager | SK Group (Group) | Île-de-France (region) |
| Istolainen, Simon (Cure51 202403 Chief Strategy + Scientific Network Officer + Co-Founder) | Business Development Manager / Strategy Manager | Cure51 SAS | Île-de-France (region) |
| Jablonka, Bernd (Sanofi 201710 Strategy + Business Development, Public Private Partnership Sanofi Germany) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Hessen (Hesse) (federal state) |
| Jeddeloh, Jeffrey A. (DNA Script 201811– VP BusDev + Commercial Strategy before Roche + Orion Genomics) | Business Development Manager / Strategy Manager | DNA Script (Group) | California (federal state) |
| Jordan, Pablo (Definiens 201310– VP Business Development Clinical Digital Pathology before bioMérieux + Ventana) | Business Development Manager / Strategy Manager | AstraZeneca (Group) | Bayern (federal state) |
| Kornowski-Bonnet, Sophie (Roche 201202–201807 Head of Roche Partnering before Roche Pharma France LEFT 7/18) | Business Development Manager / Strategy Manager | Roche (Group) | Northwestern Switzerland (region) |
| Krishnan, Shiv (Sanofi 201810 Head of Technology Platforms, Global BusDev + Licensing) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Lagon, Sophie (Microphyt 201806– Business Development Director) | Business Development Manager / Strategy Manager | Microphyt S.A. | Occitanie (Occitania) (region) |
| Legoll, Agnes (Alsace BioValley 201611 European + International Director) | Business Development Manager / Strategy Manager | Alsace BioValley | Grand Est (Great East) (region) |
| Lévy, Jean-Michel (sanofi-aventis 2007 Senior VP BusDev) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Malgouyres, Pascale (Poxel 200904– Business Development Director) | Business Development Manager / Strategy Manager | Poxel (Group) | Auvergne-Rhône-Alpes (region) |
| Mansuri, Muzammil (Muz) (F-Prime Capital 202206 Venture Partner before Sanofi + Gilead Sciences + CGI Pharma + BMS) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Martin, Helen (MedinCell 202211 Head of Alliances) | Business Development Manager / Strategy Manager | MedinCell (Group) | Occitanie (Occitania) (region) |
| Martineau, Frédéric (IntercontinentalExchange 201405 Manager International Listing at Euronext Paris) | Business Development Manager / Strategy Manager | Euronext (Group) | Île-de-France (region) |
| Menghini, Monica (Dassault Systèmes 201605 EVP + Chief Strategy Officer) | Business Development Manager / Strategy Manager | Dassault Systèmes (3DS) (Group) | Île-de-France (region) |
| Merino, Blandine (Freenome 201803 VP Business Development) | Business Development Manager / Strategy Manager | Freenome (Group) | California (federal state) |
| Michel, Aude (Onxeo 201607 Head of Corporate Development also in charge of IP) | Business Development Manager / Strategy Manager | Onxeo (Group) | Île-de-France (region) |
| Miniou, Pierre (Vivalis 200904 Director BusDev) | Business Development Manager / Strategy Manager | Valneva (Group) | Pays de la Loire (region) |
| Mogabure, Peio (Bruker 201012 Microbiology Business Developm Manager Bruker Daltonique SA) | Business Development Manager / Strategy Manager | Bruker (Group) | Grand Est (Great East) (region) |
| Montagnini, Benedetta (Metrion Biosciences 202206– Head of European BusDev before DiscoveRx + Invitrogen) | Business Development Manager / Strategy Manager | Metrion Biosciences Ltd. | East of England (region) |
| Moss, Parker (Exscientia 202401– EPV Corporate Development before Genomics England + F-Prime + Eight Roads) | Business Development Manager / Strategy Manager | Exscientia (Group) | South East England (region) |
| Mouret, Jean-François (Genostar 2004 Director Business Develop) | Business Development Manager / Strategy Manager | Genostar (Group) | Île-de-France (region) |
| Mühlenweg, Bernd (Nanobiotix 2011– Head Business Development before 2001–2011 Head BusDev at Wilex AG) | Business Development Manager / Strategy Manager | Nanobiotix (Group) | Île-de-France (region) |
| Naclerio, Nicholas J. (Nick) (Illumina 201512 SVP Corp + Venture before Quanterix + ParAllele + Zymoyx + Motorola) | Business Development Manager / Strategy Manager | Illumina (Group) | California (federal state) |
| Nagle, Ashley (Remedy Biologics 202105– VP Business Development before Domain Therapeutics) | Business Development Manager / Strategy Manager | Remedy Biologics Ltd. (RemedyBio) | Ireland (cl4) |
| Naughton, Yvonne (Sanofi 201604 Head of External Science + Partnering UK + Ireland) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Nicolas, Marie-Amélie (Atlantic Bone Screen 201407 Business Development Manager at Atlanchim Pharma Sarl) | Business Development Manager / Strategy Manager | Atlantic Bone Screen (Group) | France (region/state unspecified) |
| Palge, Fabienne (F-DGSi 201408 Global Business Development Manager) | Business Development Manager / Strategy Manager | F-DGSi (FR) | Île-de-France (region) |
| Pelletier-Bressac, Isabelle (Cellectis 200606 VP BusDev) | Business Development Manager / Strategy Manager | Cellectis (Group) | Île-de-France (region) |
| Peslherbe, Christiane (France (govt) 201611 Business France) | Business Development Manager / Strategy Manager | France (govt) | Île-de-France (region) |
| Petty, Christopher J. (Chris) (908 Devices 201206 VP BusDev + Marketing + Co-founder before Thermo Fisher + Ahura) | Business Development Manager / Strategy Manager | 908 Devices (Group) | Massachusetts (federal state) |
| Picq, Camille (QPS Netherlands B.V. 201611 Director BusDev Southern Europe) | Business Development Manager / Strategy Manager | QPS (Group) | Groningen (province) |
| Rivet, Sarah (GIE Eurasanté 201709 Business Project Officer) | Business Development Manager / Strategy Manager | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Rochlin, Kate (Nanobiotix 201905– Director of Business Development at Curadigm) | Business Development Manager / Strategy Manager | Nanobiotix (Group) | |
| Roman, Francois J. (Amylgen 201510 Head Business Development + Co-Founder before Euroscreen + Pfizer) | Business Development Manager / Strategy Manager | Amylgen SAS | Occitanie (Occitania) (region) |
| Sarros, Ilias (AXA 202401 Senior Development Manager at Kadans Science Partner Germany GmbH) | Business Development Manager / Strategy Manager | Axa (Group) | Nordrhein-Westfalen (federal state) |
| Satola, Margaux (Eurosanté 201704 Business Development Manager) | Business Development Manager / Strategy Manager | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Saunders, Michael (Elitech Group 200808 VP Marketing + BusDev) | Business Development Manager / Strategy Manager | Elitech (Group) | Île-de-France (region) |
| Schoreel, Anaïs (Eurasanté 201709 Business Development Manager) | Business Development Manager / Strategy Manager | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Sidhoum, Marjorie (Domain Therapeutics 202205 Director of Business Development) | Business Development Manager / Strategy Manager | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
| Silverstein, Jordan (Immatics 202003 Head of Corporate Strategy before InflaRx + Advanced Accelerator Applications) | Business Development Manager / Strategy Manager | Immatics (Group) | Netherlands_o |
| Spence, Gavin (Nicox 201607 EVP Corporate Development) | Business Development Manager / Strategy Manager | Nicox (Group) | Provence-Alpes-Côte d’Azur (region) |
| Steimer, Guillaume (Excelya 202007 Strategic Development Director) | Business Development Manager / Strategy Manager | Excelya (Group) | Île-de-France (region) |
| Touchon, Pascal (Atara Biotherapeutics 201906– CEO before Novartis +Servier) | Business Development Manager / Strategy Manager | Atara Biotherapeutics (Group) | California (federal state) |
| Van der Geyten, Serge (JnJ 201501 Director for Neuroscience External Affairs at Janssen Pharmaceutica NV) | Business Development Manager / Strategy Manager | Johnson & Johnson (JnJ) (Group) | Flanders (Flemish region) |
| Vnuk, Monika (Pfizer 201903 Senior Executive Worldwide Business Development) | Business Development Manager / Strategy Manager | Pfizer (Group) | New York (federal state) |
| Wacker, Ron (SGS 201106– Global BusDev Manager Food Testing before Danone + Chimera Biotec) | Business Development Manager / Strategy Manager | SGS (Group) | Région Lémanique (region) |
| Wagner, Julian (Pevion Biotech 201110 Business Development) | Business Development Manager / Strategy Manager | Pevion Biotech AG | Espace Mittelland (region) |
| Ward, Nagib (Deinove 201307– VP Business Development before Novozymes North America Inc) | Business Development Manager / Strategy Manager | Deinove S.A. (Euronext Growth: ALDEI.PA) | Île-de-France (region) |
| Woker, Mathias (AMSilk 201210– CBO located in Boston before Graffinity 200603 Senior VP BusDev US) | Business Development Manager / Strategy Manager | AMSilk GmbH | Bayern (federal state) |
| Zenker, Matthias (GAIA 201702 Business Development) | Business Development Manager / Strategy Manager | GAIA AG | Hamburg (federal state) |
| Zuliani, Vincent (GenoSafe 201611 Business Development Director) | Business Development Manager / Strategy Manager | GenoSafe SAS | Île-de-France (region) |
| Agarwal, Shefali (Onxeo 202201 Board Chairwoman) | Board member, non-executive | Onxeo (Group) | Île-de-France (region) |
| Bennani, Youssef (Domain Therapeutics 202205 Board Chairman) | Board member, non-executive | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
| Boehm, Rainer (Cellectis 201706– Board Member before 29y at Novartis) | Board member, non-executive | Cellectis (Group) | Île-de-France (region) |
| Brailly, Hervé (Innate Pharma 201612– Chairman of Supervisory Board before CEO + Co-Founder) | Board member, non-executive | Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA) | Provence-Alpes-Côte d’Azur (region) |
| Cawthorn, Robert (Actelion –201109 existent Chairman of Board Directors TO LEAVE BOARD in 2012) | Board member, non-executive | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
| Clancy, Annette (Enyo Pharma 201806 Chair of Board of Directors) | Board member, non-executive | Enyo Pharma S.A. | Auvergne-Rhône-Alpes (region) |
| Clark, Ian T. (Kite Pharma 201701– Non-executive Board Director before Roche/Genentech + Novartis + Sanofi + Ivax) | Board member, non-executive | Gilead Sciences (Group) | California (federal state) |
| Colowick, Alan (Matrix Capital Management 202206) | Board member, non-executive | Matrix Capital (Group) | Massachusetts (federal state) |
| Fellner, Peter (Acambis 200703 President) | Board member, non-executive | Sanofi (Group) [since May 2011] | East of England (region) |
| Gemayel, Georges (201511 Non-executive Board Member of Supernus + Rapotr + Dimension + Enterome + OxThera + Orphazyme) | Board member, non-executive | Enterome S.A. | Île-de-France (region) |
| Goupit, Philippe (MedDay 201501– Non-executive Board Director before Sanofi VP Corporate Licenses) | Board member, non-executive | MedDay Pharmaceuticals SAS | Île-de-France (region) |
| Hascoët, Gérard (CorWave 201611 Board Chairman) | Board member, non-executive | CorWave S.A. | Île-de-France (region) |
| Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007) | Board member, non-executive | Celyad (Group) | Belgium_o |
| Jones, Frank (Schlumberger 200305 + InforSense Board Director 200305–) | Board member, non-executive | Schlumberger (Group) | Île-de-France (region) |
| Kay, Andrew (NuCana 202012– Board Chairman also at Boards of NeRRe Tx + Blueberry Tx former CEO of Algeta) | Board member, non-executive | NuCana plc (Nasdaq: NCNA) | Scotland |
| Lefèvre, Jean-Marie (MaaT Pharma 2018–202306 Board Chairman) | Board member, non-executive | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | Auvergne-Rhône-Alpes (region) |
| Loria, Emile (OSE Pharma 201602 Chairman + main shareholder) | Board member, non-executive | OSE Immunotherapeutics (Group) | Île-de-France (region) |
| Machielse, Ben (Mosanna Therapeutics 202207 Board Chair before Vtesse + Omthera Pharmaceuticals) | Board member, non-executive | Mosanna Therapeutics AG | Northwestern Switzerland (region) |
| McKillop, Tom (former CEO of AstraZeneca) | Board member, non-executive | AstraZeneca (Group) | East of England (region) |
| Meier, Thomas (Viopas Venture Consulting 202201 Managing Partner before Santhera Pharmaceuticals) | Board member, non-executive | Viopas Venture Consulting (VVC) (Group) | Northwestern Switzerland (region) |
| Michel, André (Aureus Pharma 200612– Board Chairman before founder + CEO) | Board member, non-executive | Reed Elsevier (Group) | Île-de-France (region) |
| Mouney, Jean-François (Genfit 201909– Board Chairman before 1999–201909 CEO + Co-Founder) | Board member, non-executive | Genfit (Group) | Hauts-de-France (Upper France) (region) |
| Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH) | Board member, non-executive | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
| Oesterle, Stephen (Steve) (Sigilon Therapeutics 201706 Non-exe Board Director formerly SVP Medicine + Techn Medtronic) | Board member, non-executive | Eli Lilly (Group) | Massachusetts (federal state) |
| O’Neill, Julie (Hookipa 201811– non-exec Board Member as well as at DBV Technologies before Alexion + Gilead) | Board member, non-executive | Hookipa (Group) | New York (federal state) |
| Pasternak, Richard (Abionyx 201909– Board Chairman before CEO of predecessor Cerenis) | Board member, non-executive | Abionyx (Group) | Occitanie (Occitania) (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
